bioRxivPharmacology & Toxicology
Longitudinal effects of using and discontinuing CNS medications on cognitive functioning
Abstract
PurposeTo investigate the longitudinal effect of using and discontinuing central nervous system (CNS) medications on cognitive performance. MethodsUsing longitudinal cognitive data from healthy adults aged 25-100 years (N = 2,188) from four test waves five years apart, we investigated both the link between use of CNS medications (opioids, antidepressants, and anxiolytics, hypnotics and sedatives) on cognitive task performance (episodic memory, semantic memory, visuospatial ability) across 15 years, and the effect of discontinuing these medications in linear mixed effects models. ResultsWe found that opioid use was associated with decline in visuospatial ability, whereas antidepressant use was associated with decline in semantic memory over 15 years. A link between drug discontinuation and cognitive improvement was seen for opioids, antidepressants as well as for anxiolytics, hypnotics and sedatives. ConclusionsAlthough our results may be confounded by subjacent conditions, they suggest that long-term use of CNS medications may have domain-specific negative effects on cognitive performance over time, whereas the discontinuation of these medications may partly reverse these effects. These results open up for future studies that address subjacent conditions on cognition to develop a more complete understanding of the cognitive effects of CNS medications. Key pointsO_LIOpioid use was associated with decline in visuospatial ability, and individuals discontinuing using opioids showed improvement in visuospatial ability compared to individuals continuing using opioids. C_LIO_LIAntidepressant use was associated with decline in semantic memory, and individuals discontinuing using antidepressants showed improvement in semantic memory compared to individuals continuing using antidepressants. C_LIO_LIFor anxiolytics, hypnotics and sedatives there was no difference between continued users and non-users, but drug discontinuation was associated with more positive cognitive development both in episodic memory and visuospatial ability. C_LI
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance
Martin J. Dahl, Shelby L. Bachman, … Mara Mather·bioRxiv·Oct 12, 2022
- Effects of oral cannabidiol (CBD) on spontaneous opioid withdrawal in male and female rats
Bryan W. Jenkins, Cerina Pang, … Catherine F. Moore·Experimental and Clinical PsychopharmacologyPeer-reviewed·Jan 12, 2026
- The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators.
Christina M. Gobin, Marek Schwendt·PsychopharmacologyPeer-reviewed·Aug 24, 2019
- Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory
Manoj K. Doss, Jason Samaha, … Joshua D. Koen·Psychological ReviewPeer-reviewed·Dec 14, 2023
- CBD lengthens sleep, shortens ripples and leads to intact simple but worse cumulative memory
Anumita Samanta, Adrian Aleman‐Zapata, … Lisa Genzel·iSciencePeer-reviewed·Oct 24, 2023
- Haloperidol-induced impairment on working memory capacity affecting long term memory performance: the binding hypothesis
Regina Vieira Guarnieri, Marcus Vinicius Alves, … Orlando Francisco Amodeo Bueno·bioRxiv·Dec 24, 2019